Genetically Modified Organism (GMO) aspects for investigational medicinal products

We would like to inform sponsors that the repository with basic information about national requirements regarding GMO aspects for investigational gene therapy products has been published in European Commission website:   https://ec.europa.eu/health/human-use/advanced-therapies/gmo_investiganional_en

 

Department of Clinical Trials on Pharmaceuticals

Date 23.01. 2018